FTC Commissioners Seem POM-Skeptical In Claims Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
“The idea that this company has built these health claims on bogus science is wrong,” says POM Wonderful counsel Edward Lazarus. But commissioners reviewing appeals of FTC’s challenge against POM’s claims for its pomegranate products appeared to believe the company made a number of implied disease claims.
You may also be interested in...
POM Wonderful Says Interviews Fall Outside FTC Advertising Scope
Claims about the benefits of pomegranate made in unpaid-for media appearances should not qualify as “advertising” under the FTC Act, argues POM Wonderful. Among the claims FTC is pursuing, POM owner Lynda Resnick told Newsweek that pomegranate juice is “40 percent as effective as Viagra.”
Judge Knocks Down FTC Substantiation Bar In POM Wonderful Case
An FTC administrative law judge says the agency cannot require randomized controlled trials to substantiate nutrient claims. POM Wonderful calls the decision “a huge win,” but the firm still received a cease-and-desist order for its pomegranate juice and supplement claims.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.